Gutierrez A, Zeberio I, Penalver FJ, Martinez-Barranco P, Perez S, Morillo D, Martin X, Nicolas C, Ferrero A, Jimenez-Ubieto A, Bastos-Oreiro M, Davila-Valls J, Calle MV, Perez M, Rodriguez G, Alonso A, Garcia-Noblejas A, Sanchez Arguello D, Knight T, Fernandez A, Lopez J, Perez De Oteyza J, Gonzalez de Villambrosia S, Perez E, Marin A, Navarro MB, Fernandez R, Gomez P, Hueso JA, Penarrubia Ponce MJ, Bravo P, Garcia-Belmonte D, De La Nuez H, Nistal S, Abrisqueta P, Ibanez F, Palomera L, Donato E, Provencio A, Infante MS, Gonzalez-Barca E. Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO. Blood Adv. 2025 Oct 14;9(19):4924-4935. doi: 10.1182/bloodadvances.2025016661. PubMed PMID: 40668613; PubMed Central PMCID: PMC12508888.
AÑO: 2025; IF: 7.1